KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Payables (2016 - 2025)

Resmed's Payables history spans 16 years, with the latest figure at $510.3 million for Q4 2025.

  • For Q4 2025, Payables rose 121.66% year-over-year to $510.3 million; the TTM value through Dec 2025 reached $510.3 million, up 121.66%, while the annual FY2025 figure was $288.1 million, 16.33% up from the prior year.
  • Payables reached $510.3 million in Q4 2025 per RMD's latest filing, down from $526.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $526.7 million in Q3 2025 to a low of $129.2 million in Q1 2021.
  • Average Payables over 5 years is $229.1 million, with a median of $189.4 million recorded in 2022.
  • Peak YoY movement for Payables: dropped 5.03% in 2023, then skyrocketed 121.66% in 2025.
  • A 5-year view of Payables shows it stood at $175.4 million in 2021, then rose by 17.41% to $205.9 million in 2022, then rose by 3.1% to $212.3 million in 2023, then rose by 8.44% to $230.2 million in 2024, then soared by 121.66% to $510.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Payables are $510.3 million (Q4 2025), $526.7 million (Q3 2025), and $288.1 million (Q2 2025).